Digital Health Program to Support Family Caregivers of Children Undergoing Growth Hormone Therapy: Qualitative Feasibility Study
- PMID: 39908086
- PMCID: PMC11840389
- DOI: 10.2196/55023
Digital Health Program to Support Family Caregivers of Children Undergoing Growth Hormone Therapy: Qualitative Feasibility Study
Erratum in
-
Correction: Digital Health Program to Support Family Caregivers of Children Undergoing Growth Hormone Therapy: Qualitative Feasibility Study.JMIR Pediatr Parent. 2025 Jul 18;8:e76508. doi: 10.2196/76508. JMIR Pediatr Parent. 2025. PMID: 40680275 Free PMC article.
Abstract
Background: Caregivers of children with growth hormone deficiency often face emotional challenges (eg, stress) associated with their children's health conditions. This psychological burden might affect children's adherence to treatment and hinder their health-related quality of life (HrQoL). This assumption is leading to seriously considering multidimensional clinical approaches to pediatric health conditions where the emotional well-being of caregivers should be accounted for to optimize children's health outcomes. Novel mobile health (mHealth) solutions based on emotional and behavioral change techniques can play a promising role because they are increasingly used within different health areas to support adaptive psychological functioning. However, whether and how mHealth solutions of this type of emotional well-being support caregivers of children with growth-related problems is an issue that needs to be clarified.
Objective: This study aimed to gather qualitative information to better understand individualized experiences of caregiving of children undergoing growth hormone therapy (GHt) and perceived barriers or facilitators for the adoption of an mHealth solution called Adhera Caring Digital Program (ACDP).
Methods: A total of 10 family caregivers were recruited at Miguel Servet Children's Hospital, and they engaged with the ACDP for 1 month. The ACDP is a mobile-based digital intervention focused on promoting the overall well-being of family caregivers which provides access to personalized education, motivational mobile-based messages, and mental well-being exercises such as mindfulness or respiratory exercises. Subsequently, an individual semistructured interview was performed to gather qualitative user experience information.
Results: The digital intervention was well-received. The ACDP was found to be useful, easy to use, and understandable, addressing all the difficulties expressed by caregivers. It was also noted to be particularly helpful at the beginning of the treatment and, for some families, became a natural tool that strengthened the parent-child relationship.
Conclusions: The ACDP is a promising and well-accepted tool that enhances the experience of patients and caregivers. It improves the management of growth hormone deficiency and promotes the overall well-being of family caregivers.
Trial registration: ClinicalTrials NCT04812665; https://clinicaltrials.gov/study/NCT04812665.
International registered report identifier (irrid): RR2-10.1186/s12911-022-01935-1.
Keywords: behavioral change; caregivers; children; digital health; feasibility study; growth hormone deficiency; health condition; mHealth; mobile Health; mobile based solutions; parent-child relationship; pediatric; psychological burden; quality of life; technology acceptance; therapy; wellbeing.
©Alba Jiménez-Díaz, Maitena Pierantonelli, Patricia Morte Coscolín, Amaia Salinas-Uhalte, Silvia Quer-Palomas, Octavio Rivera-Romero, Rocío Herrero, Luis Fernández-Luque, Rosa Baños, Ricardo C Berrios, Antonio de Arriba. Originally published in JMIR Pediatrics and Parenting (https://pediatrics.jmir.org), 05.02.2025.
Conflict of interest statement
Conflicts of Interest: This study is about a digital solution developed and commercialized by Adhera Health. Adhera Health, AA, and OR-R have other collaborations with Merck Healthcare KGaA beyond this study.
Figures
Similar articles
-
Digital health for emotional and self-management support of caregivers of children receiving growth hormone treatment: a feasibility study protocol.BMC Med Inform Decis Mak. 2022 Aug 13;22(1):215. doi: 10.1186/s12911-022-01935-1. BMC Med Inform Decis Mak. 2022. PMID: 35964116 Free PMC article.
-
Empowering Caregiver Well-Being With the Adhera Caring Digital Program for Family Caregivers of Children Living With Type 1 Diabetes: Mixed Methods Feasibility Study.JMIR Pediatr Parent. 2025 Jul 9;8:e66914. doi: 10.2196/66914. JMIR Pediatr Parent. 2025. PMID: 40632783 Free PMC article.
-
Sexual Harassment and Prevention Training.2024 Mar 29. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2024 Mar 29. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 36508513 Free Books & Documents.
-
Home treatment for mental health problems: a systematic review.Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150. Health Technol Assess. 2001. PMID: 11532236
-
Factors that influence parents' and informal caregivers' views and practices regarding routine childhood vaccination: a qualitative evidence synthesis.Cochrane Database Syst Rev. 2021 Oct 27;10(10):CD013265. doi: 10.1002/14651858.CD013265.pub2. Cochrane Database Syst Rev. 2021. PMID: 34706066 Free PMC article.
References
-
- Dattani MT, Malhotra N. A review of growth hormone deficiency. Paediatrics and Child Health. 2019;29(7):285–292. doi: 10.1016/j.paed.2019.04.001. - DOI
-
- Cutfield WS, Derraik JGB, Gunn AJ, Reid K, Delany T, Robinson E, Hofman PL. Non-compliance with growth hormone treatment in children is common and impairs linear growth. PLoS One. 2011;6(1):e16223. doi: 10.1371/journal.pone.0016223. https://dx.plos.org/10.1371/journal.pone.0016223 - DOI - DOI - PMC - PubMed
-
- Savage MO, Fernandez-Luque L, Graham S, van Dommelen P, Araujo M, de Arriba A, Koledova E. Adherence to r-hGH therapy in pediatric growth hormone deficiency: current perspectives on how patient-generated data will transform r-hGH treatment towards integrated care. Patient Prefer Adherence. 2022;16:1663–1671. doi: 10.2147/PPA.S271453. https://europepmc.org/abstract/MED/35846871 271453 - DOI - PMC - PubMed
-
- Fisher BG, Acerini CL. Understanding the growth hormone therapy adherence paradigm: a systematic review. Horm Res Paediatr. 2013;79(4):189–196. doi: 10.1159/000350251. https://doi.org/10.1159/000350251 000350251 - DOI - DOI - PubMed
Associated data
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous